This is the only high-throughput aggregation assay kit on the market for both purified and cell culture supernatant samples.
It provides high-throughput analysis of aggregation (HMWS) of:
- Monoclonal antibodies
- Bi- or multispecific antibodies
- Fc fusion biologics
Benchmarked against gold standard SEC
- No reagents
- No sample prep
- 15 min for 192 samples
Watch the video below:
More on PAIA
PAIA Biotech has developed a high throughput platform technology for the quantification and glycan analysis of antibodies and proteins. Their proprietary based technology features bead-based immunoassays with fluorescence detection in specially designed 384-well microplates which drastically simplify the workflow. PAIA Biotech focuses on products for screening applications with limited sample volume and high throughput requirements, for example, IgG quantification. PAIA Biotech GmbH also offers custom assay development. PAIA Biotech GmbH was founded in 2014 and is based in Cologne.
Ellen’s take on this product
User friendly: Using the same technology as the antibody quantification assays, the plate-based glycan screening assays provide a fast and easy solution to analysing glycans during bioprocessing. This allows the researcher to monitor product quality earlier in the bioprocessing workflow.
Tailored:These easy-to-use kits come with everything you need to perform rapid screening for critical glycan features.